Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitrostudyZhe Zhang, Yanhong Wang|BMC Medicine|2009Cited by 147
Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinomaLi-fen Deng, Yanhong Wang|BMC Cancer|2013Cited by 21
Silencing of IL13RA2 promotes partial epithelial‐mesenchymal transition in hepatocellular carcinoma via ERK signaling pathway activationMimi Wang, Yanhong Wang|FEBS Open Bio|2019Cited by 6